Not too much, not too little, just right: the unexpected role of adenosine in the antitumor immune response
Más información
Fecha de publicación: | 2022 |
Objetivos: | 1. Analyze CD73 and A2AR expression on TPEX and TEX within the tumor 2. Evaluate the role of CD73 and adenosine signaling on the differentiation of TPEX cells 3. Study the impact of immunotherapeutic strategies using a-PD1 mAb and total blockade of A2AR signaling on the frequency of TPEX and TEX |
Instrumento: | FONDECYT |
Año de Inicio/Término: | 2022-2026 |
Financiamiento/Sponsor: | CONICYT |
Rol del Usuario: | COINVESTIGADOR(A) |